ISAAC LOPEZ: Open Payments
NPI 1649761297 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 91 payments from 19 companies in 2025. Trend: 2023 $1,527 · 2024 $2,033 · 2025 $1,883
Food & beverage: $1,883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $443 |
| Novo Nordisk Inc | 16 | $255 |
| Lilly USA, LLC | 8 | $192 |
| GlaxoSmithKline, LLC. | 4 | $111 |
| Astellas Pharma US Inc | 5 | $107 |
| Sumitomo Pharma America, Inc. | 4 | $106 |
| PFIZER INC. | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Viatris Specialty LLC | 1 | $86 |
Products named: JARDIANCE, LINZESS, Wegovy, TRELEGY ELLIPTA, UBRELVY, Veozah, GEMTESA, Ozempic.
Industry payments across TX — which companies pay providers there.
